| Literature DB >> 30286742 |
Severin Rakic1, Budimka Novakovic2, Sinisa Stevic3, Jelena Niskanovic4.
Abstract
BACKGROUND: Regulation of private health care providers (PHPs) in middle-income countries can be challenging. Mandatory safety and quality standards for PHPs have been in place in the Republic of Srpska since 2012, but not all PHPs have adopted them yet. Adoption rates have differed among different types of providers. We studied three predominant types of PHPs to determine why the rate of adoption of the standards varies among them.Entities:
Keywords: Certification; Diffusion of innovation; Enforcement; Mixed methods; Multiple case study; Patient safety; Private health care providers; Quality of health care; Regulation; Standards
Mesh:
Year: 2018 PMID: 30286742 PMCID: PMC6172732 DOI: 10.1186/s12939-018-0806-0
Source DB: PubMed Journal: Int J Equity Health ISSN: 1475-9276
Structure of certification standards for pharmacies, specialist practices and dental practices
| Pharmacies | Specialist practices | Dental practices | |||
|---|---|---|---|---|---|
| 1. | Management of the pharmacy | 1. | Management of the practice | 1. | Management of the practice |
| 1.1 Legal status of the pharmacy | 1.1 Legal status of the practice | 1.1 Legal status of the practice | |||
| 1.2 Human resource management | 1.2 Human resource management | 1.2 Human resource management | |||
| 1.3 Control of documents | 1.3 Control of documents | 1.3 Control of documents | |||
| 1.4 Risk management (adverse events) | 1.4 Risk management (adverse events) | 1.4 Risk management (adverse events) | |||
| 1.5 Fire protection and occupational safety | 1.5 Fire protection and occupational safety | 1.5 Fire protection and occupational safety | |||
| 1.6 Safe environment for staff and patients | 1.6 Safe environment for staff and patients | ||||
| 1.7 Equipment in the practice | 1.7 Equipment in the practice | ||||
| 2. | Services provided by the pharmacy | 2. | Safety of services | 2. | Dental services |
| 2.1 Safety of services | |||||
| 2.1 Communication with patients | 2.1 Information and communication with patients | 2.2 Information and communication with patients | |||
| 2.2 Self-care and self-medication | |||||
| 2.3 Patients’ rights | |||||
| 3. | Documentation in the pharmacy | 3. | Medical documentation | 3. | Medical documentation |
| 4. | Staff of the pharmacy | 4. | Staff of the practice | 4. | Staff of the practice |
| 5. | Physical conditions | 5. | Control of healthcare-acquired infections | 5. | Control of healthcare-acquired infections |
| 5.1 Premises of the pharmacy | 5.1 Cleaning of premises and surfaces | 5.1 Cleaning of premises and surfaces | |||
| 5.2 Physical accessibility | |||||
| 5.2 Hand hygiene | 5.2 Hand hygiene | ||||
| 5.3 Personal protective equipment | 5.3 Personal protective equipment | ||||
| 5.4 Prevention of exposure to blood borne viruses | 5.4 Prevention of exposure to blood borne viruses | ||||
| 5.5 Decontamination and sterilization of instruments and equipment | 5.5 Decontamination and sterilization of instruments and equipment | ||||
| 6. | Safety of medicines and pharmaceutical waste management | 5.6 Medical waste management | 5.6 Medical waste management |
Note: Based on ASKVA’s certification standards for pharmacies [50], specialist practices [51] and dental practices [52]
Fig. 1Private health care providers that adopted the certification standards by end of December 2016. Legend: Developed on the basis of ASKVA’s [23] and Ministry of Health and Social Welfare’s registry [33]
Types of diffusion research
| Type | Main dependent variable | Frequency in diffusion publications (%) |
|---|---|---|
| 1 | Earliness of knowing about an innovation by members of a social system | 5 |
| 2 | Rate of adoption of different innovations in a social system | 1 |
| 3 | Innovativeness of members of a social system | 58% |
| 4 | Opinion leadership in diffusing innovations | 3% |
| 5 | Diffusion networks | < 1% |
| 6 | Rate of adoption of innovations in different social systems | 2% |
| 7 | Communication channel use | 7% |
| 8 | Consequences of an innovation | < 1% |
| 9 | Others | 22% |
| Total | 100% |
Note: Based on analysis conducted by Rogers [29]
Adaptation of definitions from the diffusion of innovation theory to the study context
| Property of innovation | Variables | Adapted definitions |
|---|---|---|
| Perceived attributes of innovation | Relative advantage | Degree to which adoption of mandatory safety and quality standards is perceived as better than retaining status quo. It is a ratio of the expected benefits (e.g. better professional reputation, better management, improved patient satisfaction, economic profitability) and the costs of adoption (e.g. disadvantages to the provider). |
| Observability | Degree to which the results of adoption of mandatory safety and quality standards are visible to others (e.g. patients, peers, inspection, health insurance fund, line ministry) | |
| Communication channels | Mass media channels | All the means of transmitting messages, involving a mass medium (television, radio, Internet or press), through which audience of many PHPs and public got information on certification process. |
| Interpersonal channels | Face-to face exchange of information on mandatory safety and quality standards between owners of PHPs and other individuals (e.g. peers, both adopters and non-adopters of the standards; representatives of other organizations). | |
| Innovation decision process | Knowledge | Exposure of PHP’s owner to information on safety and quality standards and gaining of understanding on how the certification process functions. |
| Persuasion | Forming of PHP’s owner favorable, neutral or unfavorable attitude towards the certification standards and process. | |
| Decision | Engaging of PHP’s owner in activities leading to a choice to adopt or reject the certification standards and process. | |
| Social system | Collective innovation-decision | Choice to adopt or reject certification process that is made by consensus among the members of a health chamber or members of a professional association of private health care providers. |
Fig. 2Overview of the study process
Fig. 3Structure of the samples for qualitative data collection
Characteristics of respondents to the survey
| Respondents | Pharmacies | Specialist practices | Dental practices | Total |
|---|---|---|---|---|
| Adopters | 44 (42.7) | 12 (27.9) | 0 (0.0) | 56 (25.1) |
| Certification is ongoing | 31 (30.1) | 16 (37.2) | 17 (22.1) | 64 (28.7) |
| Non-adopters | 28 (27.2) | 15 (34.9) | 60 (77.9) | 103 (46.2) |
| Total | 103 (100.0) | 43 (100.0) | 77 (100.0) | 223 (100.0) |
Results of one-way analysis of variance, by provider types
| Subscales | Type of private health care provider | n | Mean | Standard deviation | F (p) |
|---|---|---|---|---|---|
| Relative advantages (perceived benefits) | Pharmacies | 101 | 24.59 | 7.82 | 35.906 (.000) |
| Specialist practices | 43 | 20.88 | 8.96 | ||
| Dental practices | 74 | 14.32 | 7.44 | ||
| Total | 218 | 20.38 | 9.12 | ||
| Collective innovation-decision (influence of chambers) | Pharmacies | 98 | 17.67 | 5.52 | 9.533 (.000) |
| Specialist practices | 40 | 13.77 | 6.52 | ||
| Dental practices | 70 | 14.49 | 5.57 | ||
| Total | 208 | 15.85 | 5.97 | ||
| Collective innovation-decision (influence of professional associations) | Pharmacies | 99 | 18.47 | 5.18 | 22.972(.000) |
| Specialist practices | 40 | 14.72 | 7.28 | ||
| Dental practices | 72 | 12.78 | 4.89 | ||
| Total | 211 | 15.82 | 6.10 | ||
| Relative advantages (perceived disadvantages) | Pharmacies | 102 | 19.93 | 4.50 | 5.646 (.004) |
| Specialist practices | 43 | 22.19 | 3.57 | ||
| Dental practices | 76 | 21.63 | 4.34 | ||
| Total | 221 | 20.95 | 4.37 | ||
| Observability | Pharmacies | 99 | 12.60 | 4.44 | 9.339 (.000) |
| Specialist practices | 38 | 10.42 | 4.55 | ||
| Dental practices | 69 | 9.74 | 4.29 | ||
| Total | 206 | 11.24 | 4.58 | ||
| Innovation-decision process: knowledge (availability of information on certification) | Pharmacies | 102 | 16.17 | 3.62 | 31.068 (.000) |
| Specialist practices | 42 | 13.90 | 4.75 | ||
| Dental practices | 71 | 11.30 | 4.05 | ||
| Total | 215 | 14.12 | 4.53 |
Synthesis of interviews and survey findings on providers’ perceptions of safety and quality standards’ attributes
| Type of private health care provider | Adoption of standards | Relative advantages | Observability | |
|---|---|---|---|---|
| Perceived benefits | Perceived disadvantages | |||
| Pharmacies | Adopters | Significant: | Insignificant | Observable effects: |
| Non-adopters | Insignificant | Significant: | No observable effects | |
| Specialist practices | Adopters | Uncertain significance: | Significant: | Few observable effects: |
| Non-adopters | Insignificant | Significant: | No observable effects | |
| Dental practices | Adopters | Insignificant | Insignificant | No observable effects |
| Non-adopters | Insignificant | Significant: | No observable effects | |
Note: ↑ indicates improvement (perceived benefits) or increase (perceived disadvantages)
Synthesis of interviews and survey findings on influential sources of information and frequent communication channels
| Type of private health care provider | Adoption of standards | Sources of information (ranked by influence) | Communication channels | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASKVA | Peers | Professional association | Public Health Institute | Chamber | Internet | Professional meetings | Training events | Interpersonal communication | Official correspondence | ||
| Pharmacies | Adopters | *** | ** | ✦✦✦ | ✦✦ | ✦ | |||||
| Non-adopters | ** | *** | * | ✦✦✦ | ✦✦ | ✦ | |||||
| Specialist practices | Adopters | *** | ** | * | ✦✦ | ✦✦✦ | ✦ | ||||
| Non-adopters | ** | *** | * | ✦✦ | ✦✦✦ | ✦ | |||||
| Dental practices | Adopters | *** | ✦✦✦ | ✦✦ | ✦ | ||||||
| Non-adopters | * | ** | *** | ✦✦ | ✦✦✦ | ✦ | |||||
Ranking of information sources: *** the most influential source; ** source with secondly ranked influence; * source with thirdly ranked influence
Frequency of communication channel use: ✦✦✦ the most frequently used; ✦✦ frequently used; ✦less frequently used
Fig. 4Non-adopters’ perceptions of risks related to delaying introduction of safety and quality standards. Legend: Subset of data collected through the survey
Fig. 5Perception of professional associations’ influence on adoption of the standards. Legend: Subset of data collected through the survey
Fig. 6Perception of health chambers’ influence on adoption of the standards. Legend: Subset of data collected through the survey